Sign in

NCT01861080Completed

Korean Registry of Target Organ Damages in Hypertension

Observational Study of Clinical Characteristics and Prognostic Factors of Korean Hypertensives

Source: ClinicalTrials.gov · Last updated 26 Aug 2026

Brief summary (registry, in English)

The objective of this study is to know prevalence of clinical or subclinical target organ damages in Korea hypertensives by constructing nationwide hypertension registry. We will register 5000 consecutive patients with incident hypertension at 20 major university hospitals in South Korea. We will investigate clinical/subclinical target organ damages, renin/aldosterone level and cardiovascular events in each patient.

Status (registry)
Completed
Study type
Observational
Enrollment
3000 (estimated)
First submitted
16 May 2013
Start date
21 Dec 2012
Primary completion date
4 Apr 2025
Lead sponsor
Dongtan Sacred Heart Hospital
NCT number
NCT01861080

What you commit to

  • Study type: Observational
  • Planned participants: 3000
  • From 21 Dec 2012 to the primary completion date, 4 Apr 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • participated in other clinical trials

Who the study is looking for

  • age≧30years
  • primary incident hypertension
  • singed informed consent

Age in the registry: 30 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Hallym University Dongtan Sacred Heart Hospital
Coordinator of this site? Confirm its status
HwaseongSouth KoreaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.